Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02012322 · ClinicalTrials.gov registry record · NA
UCSD Q10 and Aging Study
A NA study of Age Related Symptoms and Age Related Quality of Life Issues, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT02012322 is a NA study of Age Related Symptoms and Age Related Quality of Life Issues that has completed, run by University of California, San Diego. The registered enrollment target is 44 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02012322, a NA study of Age Related Symptoms and Age Related Quality of Life Issues, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
Goal: The investigators propose to test the feasibility of giving the supplement coenzyme Q10 (Q10) improves symptoms and subjective health in an aging population. Rationale: Direct empirical evidence has supported benefit of Q10 to many symptoms such as fatigue, muscle pain, and cognition. In addition, Q10 has also been reported to benefit other symptoms including headaches, sleep disturbances, and breathing problems. This provides a strong rationale for testing whether Q10 will have similar benefit to these symptoms in an aging population. Method: 44 aging subjects will participate. The design is a 9 month, randomized, double-blind, placebo-controlled crossover study. Each subject will be "crossed over" between high dose Q10 (300mg), low dose Q10 (100mg), and placebo, receiving each agent for 3 month periods. Neither subjects nor investigators will know which substance each subject is receiving in which phase. Subjects will be randomly assigned to one of six arms. Assessments: Assessments will include feasibility of study, subjective quality of life, energy, and metabolic and lipid panels. Analyses will show whether Q10 led to improvements when compared to placebo; whether higher Q10 doses improved outcomes more than lower doses; and whether people with certain symptoms or characteristics get more benefit than people with other symptoms or characteristics.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Coenzyme Q10
Study Locations (1)
California
- UCSD General Clinical Research Center - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02012322
The ClinicalTrials.gov registry entry for NCT02012322 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Age Related Symptoms appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02012322 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02012322 about?
NCT02012322 is a clinical study titled "UCSD Q10 and Aging Study". Goal: The investigators propose to test the feasibility of giving the supplement coenzyme Q10 (Q10) improves symptoms and subjective health in an aging population. Rationale: Direct empirical evidence has supported benefit of Q10 to many symptoms such as fatigue, muscle pain, and cognition. In addi...
What is the current status of trial NCT02012322?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2008-11. Estimated completion is 2009-07.
What conditions does trial NCT02012322 study?
This clinical trial studies the following conditions: Age Related Symptoms, Age Related Quality of Life Issues.
What interventions are being tested in trial NCT02012322?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Coenzyme Q10 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02012322?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02012322 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.